It has been reported that the down-regulation of IRF4 and MYC via IKZF1 and IKZF3 degradation is a key mechanism underlying the anti-proliferative effect of Le and pomalidomide (Po) in MM cells5,6,36. Here, IKZF3 is linked to Miyoshi myopathy.